Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,300
Closed -$367K 285
2025
Q3
$367K Hold
1,300
0.06% 188
2025
Q2
$363K Hold
1,300
0.06% 191
2025
Q1
$405K Hold
1,300
0.07% 177
2024
Q4
$339K Hold
1,300
0.06% 204
2024
Q3
$419K Buy
+1,300
New +$425K 0.07% 180

Other funds holding AMGN

Insight Advisors's AMGN Position: Q2 2026 in Review

Insight Advisors reduced its Amgen (AMGN) stake by 1.2% in Q2 2026, selling an estimated $7.87K and leaving 1,857 shares worth $672K. The position accounts for 0.12% of the portfolio, ranked #111.

Insight Advisors first reported a position in AMGN in Q4 2020 and has held it in 23 quarters since. The position peaked at $703K in Q4 2022. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Insight Advisors held 1,857 shares of Amgen worth $672K as of Q2 2026.
  • Insight Advisors sold 23 Amgen shares in Q2 2026, an estimated $7.87K.
  • Amgen made up 0.12% of Insight Advisors's portfolio in Q2 2026, its #111 holding.
  • Insight Advisors first reported a position in Amgen in Q4 2020 and has held it in 23 quarters since.
  • Insight Advisors's Amgen position peaked at $703K in Q4 2022.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Insight Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.